139 related articles for article (PubMed ID: 3346542)
1. Effect of gangliosides on activation of the alternative pathway of human complement.
Michalek MT; Bremer EG; Mold C
J Immunol; 1988 Mar; 140(5):1581-7. PubMed ID: 3346542
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of the alternative pathway of human complement by structural analogues of sialic acid.
Michalek MT; Mold C; Bremer EG
J Immunol; 1988 Mar; 140(5):1588-94. PubMed ID: 3346543
[TBL] [Abstract][Full Text] [Related]
3. The influence of membrane components on regulation of alternative pathway activation by decay-accelerating factor.
Mold C; Walter EI; Medof ME
J Immunol; 1990 Dec; 145(11):3836-41. PubMed ID: 1700997
[TBL] [Abstract][Full Text] [Related]
4. Effect of membrane phospholipids on activation of the alternative complement pathway.
Mold C
J Immunol; 1989 Sep; 143(5):1663-8. PubMed ID: 2527270
[TBL] [Abstract][Full Text] [Related]
5. Requirements for beta1H globulin and C3b inactivator in the control of the alternative complement pathway in human serum.
Whaley K; Thompson RA
Immunology; 1978 Dec; 35(6):1045-9. PubMed ID: 83964
[TBL] [Abstract][Full Text] [Related]
6. Prevention of immune precipitation by purified components of the alternative pathway.
Naama JK; Holme E; Hamilton E; Whaley K
Clin Exp Immunol; 1985 Apr; 60(1):169-77. PubMed ID: 3159522
[TBL] [Abstract][Full Text] [Related]
7. Activation of the alternative pathway of complement by human peripheral nerve myelin.
Koski CL; Vanguri P; Shin ML
J Immunol; 1985 Mar; 134(3):1810-4. PubMed ID: 2578522
[TBL] [Abstract][Full Text] [Related]
8. CR2 is a complement activator and the covalent binding site for C3 during alternative pathway activation by Raji cells.
Mold C; Nemerow GR; Bradt BM; Cooper NR
J Immunol; 1988 Mar; 140(6):1923-9. PubMed ID: 2831273
[TBL] [Abstract][Full Text] [Related]
9. Antibody-mediated alternative complement pathway activation resists inhibition by sialoglycolipids.
Okada N; Yasuda T; Okada H
J Immunol; 1985 May; 134(5):3316-9. PubMed ID: 2580023
[TBL] [Abstract][Full Text] [Related]
10. Eosinophil granule major basic protein regulates generation of classical and alternative-amplification pathway C3 convertases in vitro.
Weiler JM; Gleich GJ
J Immunol; 1988 Mar; 140(5):1605-10. PubMed ID: 3346544
[TBL] [Abstract][Full Text] [Related]
11. The role of surface charge in the activation of the classical and alternative pathways of complement by liposomes.
Chonn A; Cullis PR; Devine DV
J Immunol; 1991 Jun; 146(12):4234-41. PubMed ID: 2040798
[TBL] [Abstract][Full Text] [Related]
12. Induction of granulocyte histaminase release by particle-bound complement C3 cleavage products (C3b, C3bi) and IgG.
Melamed J; Medicus RG; Arnaout MA; Colten HR
J Immunol; 1983 Jul; 131(1):439-44. PubMed ID: 6223078
[TBL] [Abstract][Full Text] [Related]
13. Human alternative complement pathway: membrane-associated sialic acid regulates the competition between B and beta1 H for cell-bound C3b.
Kazatchkine MD; Fearon DT; Austen KF
J Immunol; 1979 Jan; 122(1):75-81. PubMed ID: 762425
[No Abstract] [Full Text] [Related]
14. Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b.
Kazatchkine MD; Fearon DT; Silbert JE; Austen KF
J Exp Med; 1979 Nov; 150(5):1202-15. PubMed ID: 501288
[TBL] [Abstract][Full Text] [Related]
15. Evasion of the alternative complement pathway by metacyclic trypomastigotes of Trypanosoma cruzi: dependence on the developmentally regulated synthesis of surface protein and N-linked carbohydrate.
Sher A; Hieny S; Joiner K
J Immunol; 1986 Nov; 137(9):2961-7. PubMed ID: 3531342
[TBL] [Abstract][Full Text] [Related]
16. Metabolism of C3 and factor B in patients with congenital factor I deficiency.
Rasmussen JM; Teisner B; Brandt J; Brandslund I; Gry H
J Clin Lab Immunol; 1990 Feb; 31(2):59-67. PubMed ID: 1966986
[TBL] [Abstract][Full Text] [Related]
17. Activation of the alternative pathway of human complement by haemoglobin.
Wilson WA; Thomas EJ
Clin Exp Immunol; 1979 Apr; 36(1):140-4. PubMed ID: 111881
[TBL] [Abstract][Full Text] [Related]
18. Alternative pathway complement activation in rheumatoid arthritis.
El-Ghobarey A; Whaley K
J Rheumatol; 1980; 7(4):453-60. PubMed ID: 6158571
[TBL] [Abstract][Full Text] [Related]
19. In vitro activation of complement by isolated human heart subcellular membranes.
Giclas PC; Pinckard RN; Olson MS
J Immunol; 1979 Jan; 122(1):146-51. PubMed ID: 762412
[TBL] [Abstract][Full Text] [Related]
20. Activation of the alternative pathway of complement by cellulosic hemodialysis membranes.
Cheung AK; Parker CJ; Wilcox L; Janatova J
Kidney Int; 1989 Aug; 36(2):257-65. PubMed ID: 2528653
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]